190 related articles for article (PubMed ID: 15480979)
1. Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2.
Udd L; Katajisto P; Rossi DJ; Lepistö A; Lahesmaa AM; Ylikorkala A; Järvinen HJ; Ristimäki AP; Mäkelä TP
Gastroenterology; 2004 Oct; 127(4):1030-7. PubMed ID: 15480979
[TBL] [Abstract][Full Text] [Related]
2. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis.
Rossi DJ; Ylikorkala A; Korsisaari N; Salovaara R; Luukko K; Launonen V; Henkemeyer M; Ristimaki A; Aaltonen LA; Makela TP
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12327-32. PubMed ID: 12218179
[TBL] [Abstract][Full Text] [Related]
3. Correlation of staining for LKB1 and COX-2 in hamartomatous polyps and carcinomas from patients with Peutz-Jeghers syndrome.
Wei C; Amos CI; Rashid A; Sabripour M; Nations L; McGarrity TJ; Frazier ML
J Histochem Cytochem; 2003 Dec; 51(12):1665-72. PubMed ID: 14623934
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cyclooxygenase 2 in hamartomatous polyps of Peutz-Jeghers syndrome.
McGarrity TJ; Peiffer LP; Amos CI; Frazier ML; Ward MG; Howett MK
Am J Gastroenterol; 2003 Mar; 98(3):671-8. PubMed ID: 12650805
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling.
Wei C; Amos CI; Zhang N; Wang X; Rashid A; Walker CL; Behringer RR; Frazier ML
Clin Cancer Res; 2008 Feb; 14(4):1167-71. PubMed ID: 18281551
[TBL] [Abstract][Full Text] [Related]
6. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
7. N-methylnitrosourea aggravates gastrointestinal polyposis in Lkb1+/- mice.
Udd L; Gao Y; Ristimäki AP; Mäkelä TP
Carcinogenesis; 2013 Oct; 34(10):2409-14. PubMed ID: 23722652
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive efficacy of rapamycin on Peutz-Jeghers syndrome in a mouse model.
Wei C; Amos CI; Zhang N; Zhu J; Wang X; Frazier ML
Cancer Lett; 2009 May; 277(2):149-54. PubMed ID: 19147279
[TBL] [Abstract][Full Text] [Related]
9. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis.
Steinbach G; Lynch PM; Phillips RK; Wallace MH; Hawk E; Gordon GB; Wakabayashi N; Saunders B; Shen Y; Fujimura T; Su LK; Levin B; Godio L; Patterson S; Rodriguez-Bigas MA; Jester SL; King KL; Schumacher M; Abbruzzese J; DuBois RN; Hittelman WN; Zimmerman S; Sherman JW; Kelloff G
N Engl J Med; 2000 Jun; 342(26):1946-52. PubMed ID: 10874062
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention comes to clinical practice: COX-2 inhibition in familial adenomatous polyposis.
Bresalier RS
Gastroenterology; 2000 Dec; 119(6):1797-8. PubMed ID: 11113106
[No Abstract] [Full Text] [Related]
11. Nasal polyposis in Peutz-Jeghers syndrome: a distinct histopathological and molecular genetic entity.
de Leng WW; Westerman AM; Weterman MA; Jansen M; van Dekken H; Giardiello FM; de Rooij FW; Paul Wilson JH; Offerhaus GJ; Keller JJ
J Clin Pathol; 2007 Apr; 60(4):392-6. PubMed ID: 16775120
[TBL] [Abstract][Full Text] [Related]
12. Selective COX-2 inhibitors as chemopreventive and therapeutic agents.
Grossman HB
Drugs Today (Barc); 2003 Mar; 39(3):203-12. PubMed ID: 12730704
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.
Saukkonen K; Tomasetto C; Narko K; Rio MC; Ristimäki A
Cancer Res; 2003 Jun; 63(12):3032-6. PubMed ID: 12810622
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas.
De Leng WW; Westerman AM; Weterman MA; De Rooij FW; Dekken Hv Hv; De Goeij AF; Gruber SB; Wilson JH; Offerhaus GJ; Giardiello FM; Keller JJ
Clin Cancer Res; 2003 Aug; 9(8):3065-72. PubMed ID: 12912958
[TBL] [Abstract][Full Text] [Related]
15. Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice.
Zeytin HE; Patel AC; Rogers CJ; Canter D; Hursting SD; Schlom J; Greiner JW
Cancer Res; 2004 May; 64(10):3668-78. PubMed ID: 15150127
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors in glioma therapy.
Giglio P; Levin V
Am J Ther; 2004; 11(2):141-3. PubMed ID: 14999366
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
18. Role of the Serine/Threonine Kinase 11 (STK11) or Liver Kinase B1 (LKB1) Gene in Peutz-Jeghers Syndrome.
Altamish M; Dahiya R; Singh AK; Mishra A; Aljabali AAA; Satija S; Mehta M; Dureja H; Prasher P; Negi P; Kapoor DN; Goyal R; Tambuwala MM; Chellappan DK; Dua K; Gupta G
Crit Rev Eukaryot Gene Expr; 2020; 30(3):245-252. PubMed ID: 32749111
[TBL] [Abstract][Full Text] [Related]
19. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome.
Shackelford DB; Vasquez DS; Corbeil J; Wu S; Leblanc M; Wu CL; Vera DR; Shaw RJ
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11137-42. PubMed ID: 19541609
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
Kitamura T; Itoh M; Noda T; Matsuura M; Wakabayashi K
Int J Cancer; 2004 Apr; 109(4):576-80. PubMed ID: 14991580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
